Clinical Trial Update: The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update (SAPPHO) evaluating sequential curative-intent therapy in newly diagnosed de novo HER2-positive metastatic breast cancer; recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer Female, Breast Cancer | Phase 2 | Status: RECRUITING